News dal mondo
11
Mar
EU Finalizes Pharma Reform Package, Clarifies New Rules On Modular Market Protection
A final version of the draft pharma reform package has been published, clarifying changes that the pharma industry can expect once the legal package enters into force. The legislation, which comprises a new regulation and directive, will replace the existing framework that has been in place for more than two decades. The pharma reform package introduces, among many other things, changes to market protection for new drugs in the EU. The new DIRECTIVE OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL on the Union code relating to medicinal products for human use, and repealing Directive 2001/83/EC and Directive 2009/35/EC The new REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL laying down Union procedures for the authorisation and supervision of medicinal products for human use and establishing rules governing the European Medicines Agency, amending Regulation (EC) No 1394/2007 and Regulation (EU) No 536/2014 and repealing Regulation (EC) No 726/2004, Regulation (EC) No 141/2000 and Regulation (EC) No 1901/2006
13
Dal China all’India-shoring, il rischio di una nuova dipendenza
Una ricerca universitaria, promossa da CPA Italy, sulla supply chain di principi attivi e intermedi mostra...
PFAS restriction proposal: ECHA’s Socio-Economic Analysis Committee agrees its draft opinion
The European Chemicals Agency’s Committee for Socio-Economic Analysis (SEAC) has agreed its draft opinion...
Farmaci - Gemmato: In cantiere anche un ritorno nazionale alla chimica farmaceutica di base
Il sottosegretario alla Salute Marcello Gemmato è intervenuto durante la presentazione del Rapporto...
EMA outlines methods for evaluating supply chain vulnerabilities
The European Medicines Agency (EMA) has published a document detailing its methodology for monitoring...
le ultime news
29 Gen
US FDA Announces PreCheck Implementation Roadmap
28 Gen
Industry wants more streamlining following recent EU reforms
FDA official offers tips on leveraging AI in drug manufacturing
Testo unico legislazione farmaceutica. La delega torna a Palazzo Chigi
27 Gen
Tariff Uncertainty Drives Short-Term Manufacturing Surge as Global Pharmaceuticals Enter Fragmented Growth Phase
23 Gen
Produzione di API: processi, rischi e scenari futuri
21 Gen
Farmaci. L’Europa cambia le regole: per la sicurezza sanitaria arriva il “Compra europeo”
Farmaci: OK Parlamento europeo a posizione su Medicinali Critici
<<<3 4 5>>>
